Purchases and Sales Made in Q4 2024 in T Scan Therapeutics, Inc. (TCRX)
This table provides information about the institutional ownership of T Scan Therapeutics, Inc. (TCRX) during Q4 2024. The information is specifically focused on institutions that hold shares of TScan Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-1.13K- 8.09% |
$3.3K - $6.68K
|
12.8K
$17.3K
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.89K- 23.47% |
$5.53K - $11.2K
|
6.16K
$8.32K
|
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-2.18K- 0.67% |
$6.39K - $12.9K
|
322K
$435K
|
|
|
Feb 05, 2025
Q4 2024
|
Us Bancorp \De\
|
SELL
|
- |
-2.21K- 49.41% |
$6.48K - $13.1K
|
2.27K
$3.06K
|
|
|
Feb 07, 2025
Q4 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-9.76K- 79.67% |
$28.6K - $58K
|
2.49K
$3.36K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-10.1K- 81.97% |
$29.6K - $60.1K
|
2.23K
$3K
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-10.2K- 1.05% |
$29.9K - $60.6K
|
963K
$1.3M
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-40.1K- 73.41% |
$117K - $238K
|
14.5K
$19.6K
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-63.4K- 85.68% |
$186K - $377K
|
10.6K
$14.3K
|
|
|
Feb 14, 2025
Q4 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-84.5K- 81.68% |
$248K - $502K
|
19K
$25.6K
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-121K- 73.38% |
$355K - $720K
|
44K
$59.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-900K- 20.45% |
$2.64M - $5.35M
|
3.5M
$4.73M
|